(Q54036199)

English

Pharmacokinetic and pharmacodynamic profiles of CS-518, a selective, long-lasting thromboxane synthase inhibitor, after single and multiple oral administration to healthy volunteers.

scientific article published in January 1994

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/8132850

Pharmacokinetic and pharmacodynamic profiles of CS-518, a selective, long-lasting thromboxane synthase inhibitor, after single and multiple oral administration to healthy volunteers. (English)

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/8132850

pharmacokinetics

1 reference

based on heuristic

inferred from title

pharmacodynamics

1 reference

based on heuristic

inferred from title

author name string

Uematsu T

1

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/8132850

Nagashima S

2

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/8132850

Inaba H

3

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/8132850

Mizuno A

4

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/8132850

Kosuge K

5

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/8132850

Nakashima M

6

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/8132850

publication date

1 January 1994

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/8132850

The Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/8132850

34

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/8132850

1

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/8132850

41-47

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/8132850

An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03964.X

21 January 2018

Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial.

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03964.X

21 January 2018

Effects of Y-20811, a long-lasting thromboxane synthetase inhibitor, on thromboxane production and platelet function

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03964.X

21 January 2018

Platelet and Blood Vessel Arachidonate Metabolism and Interactions

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03964.X

21 January 2018

Acetylation of prostaglandin synthase by aspirin

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03964.X

21 January 2018

A thromboxane synthetase inhibitor reorients endoperoxide metabolism in whole blood towards prostacyclin and prostaglandin E2

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB03964.X

21 January 2018

Identifiers

10.1002/J.1552-4604.1994.TB03964.X

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/8132850

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/8132850

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54036199&oldid=2144191571"